Clinical Trial Update: Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study) [Phase 4]

View source ↗

Summary

A Phase 4 COSMOS study update examining changes in methotrexate polyglutamate concentrations during subcutaneous methotrexate therapy in patients with rheumatoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Keio University | Conditions: Rheumatoid Arthritis (RA) | Phase 4 | Status: RECRUITING